Nature Communications (Nov 2020)

Collider bias undermines our understanding of COVID-19 disease risk and severity

  • Gareth J. Griffith,
  • Tim T. Morris,
  • Matthew J. Tudball,
  • Annie Herbert,
  • Giulia Mancano,
  • Lindsey Pike,
  • Gemma C. Sharp,
  • Jonathan Sterne,
  • Tom M. Palmer,
  • George Davey Smith,
  • Kate Tilling,
  • Luisa Zuccolo,
  • Neil M. Davies,
  • Gibran Hemani

DOI
https://doi.org/10.1038/s41467-020-19478-2
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 12

Abstract

Read online

Many published studies of the current SARS-CoV-2 pandemic have analysed data from non-representative samples from populations. Here, using UK BioBank samples, Gibran Hemani and colleagues discuss the potential for such studies to suffer from collider bias, and provide suggestions for optimising study design to account for this.